| Line item | 2025-11-30 FY | 2024-11-30 FY | 2023-11-30 FY | 2022-11-30 FY | 2021-11-30 FY |
|---|---|---|---|---|---|
| Revenue | $83.98M | $54.55M | $76.99M | $38.63M | $29.75M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $369.65M | $267.58M | $232.05M | $222.49M | $147.64M |
| R&D | $316.90M | $221.63M | $189.15M | $184.50M | $116.43M |
| SG&A | $52.74M | $45.94M | $42.90M | $38.00M | $31.20M |
| Operating Income | -$285.67M | -$213.03M | -$155.06M | -$183.87M | -$117.89M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $760.00K | $270.00K | $0.00 | $0.00 | $131.00K |
| Net Income | -$264.46M | -$193.57M | -$143.95M | -$180.36M | -$117.19M |
| EPS (basic) | -3.0500 | -2.8800 | -2.6500 | -3.7100 | -2.7300 |
| EPS (diluted) | -3.0500 | -2.8800 | -2.6500 | -3.7100 | -2.7300 |
| Shares (diluted) | $86.67M | $67.12M | $54.34M | $48.61M | $42.90M |